The 4 breast cancer patients had P/LP variants in BRCA1 (with ovarian cancer and thyroid cancer), BRCA2 (with endometrial cancer), BRCA2 (with thyroid cancer) and TP53 (with brain tumor). Here, BRCA2 is linked to ovarian carcinoma.